[R] Comparison of SAS & R/Splus
tlumley at u.washington.edu
Fri Sep 5 15:49:08 CEST 2003
On Fri, 5 Sep 2003, Paul, David A wrote:
> d. Because SAS is commercial software, a posteriori errors found in
> clinical trials analyses (and due to software issues) can be
> attributed by the NDA applicants to the SAS Institute.
> Lawyers really like this. Of course, Splus is also commercial
> and therefore does not suffer from criticism on these
Note, however, that one of the few specific pieces of guidance the FDA
gives on software is that it isn't sufficient to place your trust in
commercial off-the-shelf software (and of course this is reinforced by
the software licensing terms).
More information about the R-help